| Polyethylene glycol-conjugated growth hormone-releasing hormone is long acting and stimulates GH in healthy young and elderly subjects.Eur J Endocrinol | Random groups | 2005 |
| The GH response to low-dose bolus growth hormone-releasing hormone (GHRH(1-29)NH2) is attenuated in patients with longstanding post-irradiation GH insufficiency.Eur J Endocrinol | Random groups | 2000 |
| The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals.Clin Endocrinol (Oxf) | Random groups | 1999 |
| The control on growth hormone release by free fatty acids is maintained in acromegaly.J Clin Endocrinol Metab | Random groups | 1999 |
| Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation.J Clin Endocrinol Metab | Random groups | 1998 |
| Direct effects of corticotrophin-releasing hormone on stimulated growth hormone secretion.Clin Endocrinol (Oxf) | Random groups | 1998 |
| Effects of [norleucine27]growth hormone-releasing hormone (GHRH) (1-29)-NH2 administration on the immune system of aging men and women.J Clin Endocrinol Metab | Random groups | 1997 |
| Hexarelin-induced growth hormone, cortisol, and prolactin release: a dose-response study.J Clin Endocrinol Metab | Random groups | 1996 |
| The effect of repeated administration of hexarelin, a growth hormone releasing peptide, and growth hormone releasing hormone on growth hormone responsivity.Clin Endocrinol (Oxf) | Random groups | 1996 |
| Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.J Clin Invest | Random groups | 1996 |
| Aspartate and glutamate modulation of growth hormone secretion in the pig: possible site of action.Domest Anim Endocrinol | Random groups | 1996 |
| Comparison of the effects of growth hormone-releasing hormone and hexarelin, a novel growth hormone-releasing peptide-6 analog, on growth hormone secretion in humans with or without glucocorticoid excess.J Endocrinol | Random groups | 1995 |
| Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women.Metabolism | Random groups | 1995 |
| Neuroendocrine responses to a novel growth hormone secretagogue, L-692,429, in healthy older subjects.J Clin Endocrinol Metab | Random groups | 1994 |
| Low-dose growth hormone-releasing hormone tests: a dose-response study.Eur J Endocrinol | Random groups | 1994 |
| Effect of pyridostigmine on the growth hormone response to growth hormone-releasing hormone in lean and obese type II Diabetic patients.Metabolism | Random groups | 1994 |
| Physiological role of galanin in the regulation of anterior pituitary function in humans.Am J Physiol | Random groups | 1994 |
| A comparative study of growth hormone (GH) and GH-releasing hormone(1-29)-NH2 for stimulation of growth in children with GH deficiency.Acta Paediatr Suppl | Random groups | 1993 |
| Growth response to growth hormone-releasing hormone(1-29)-NH2 compared with growth hormone.Acta Paediatr Suppl | Random groups | 1993 |
| Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration.Acta Paediatr Suppl | Random groups | 1993 |
| Effect of galanin on the growth hormone (GH) response to GH-releasing hormone in patients with Cushing's disease.Endocr Res | Random groups | 1993 |
| Galanin does not affect the growth hormone-releasing hormone-stimulated growth hormone secretion in patients with hyperthyroidism.Acta Endocrinol (Copenh) | Random groups | 1992 |
| Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men.J Clin Endocrinol Metab | Random groups | 1992 |
| Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone-releasing hormone alone or in combination with pyridostigmine in type I diabetic patients.Acta Endocrinol (Copenh) | Random groups | 1991 |
| Pyridostigmine fails to increase either spontaneous or GHRH-stimulated GH secretion during day or night in growth hormone-insufficient children.Clin Endocrinol (Oxf) | Random groups | 1991 |
| Impaired growth hormone (GH) response to pyridostigmine in type 1 diabetic patients with exaggerated GH-releasing hormone-stimulated GH secretion.J Clin Endocrinol Metab | Random groups | 1990 |
| The interaction between clonidine and growth hormone releasing hormone in the stimulation of growth hormone secretion in man.Clin Endocrinol (Oxf) | Random groups | 1990 |
| Subcutaneous growth hormone-releasing hormone augments pulsatile nocturnal GH release in GH-insufficient children, but may also raise basal GH secretion.Clin Endocrinol (Oxf) | Random groups | 1990 |
| Acute effects of cortisone acetate on growth hormone response to growth hormone-releasing hormone in normal adult subjects.Acta Endocrinol (Copenh) | Random groups | 1990 |
| Evaluation of the growth-hormone-releasing hormone test in short normal and growth-hormone-deficient children.Horm Res | Random groups | 1990 |
| Growth hormone and prolactin secretion after growth hormone-releasing hormone administration, in anorexia nervosa patients, normal controls and tamoxifen-pretreated volunteers.Clin Endocrinol (Oxf) | Random groups | 1987 |
| Lack of effect of muscarinic cholinergic blockade on the GH responses to GRF 1-29 and TRH in acromegalic subjects.Clin Endocrinol (Oxf) | Random groups | 1986 |
| Influence of dopaminergic, adrenergic and cholinergic blockade and TRH administration on GH responses to GRF 1-29.Clin Endocrinol (Oxf) | Random groups | 1986 |
| Outcome of growth hormone therapy in children with growth hormone deficiency showing an inadequate response to growth hormone-releasing hormone.Endocrine | No random groups | 2001 |
| The negative GH auto-feedback in childhood: effects of rhGH and/or GHRH on the somatotroph response to GHRH or hexarelin, a peptidyl GH secretagogue, in children.J Endocrinol Invest | No random groups | 2000 |
| Interaction of the growth hormone releasing peptide hexarelin with somatostatin.Clin Endocrinol (Oxf) | No random groups | 1997 |
| Growth hormone release by the novel GH releasing peptide hexarelin in patients with homozygous beta-thalassemia.J Pediatr Endocrinol Metab | No random groups | 1997 |
| Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men.Metabolism | No random groups | 1997 |
| Long-term administration of acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid in obesity.Metabolism | No random groups | 1996 |
| Once daily subcutaneous growth hormone-releasing hormone therapy accelerates growth in growth hormone-deficient children during the first year of therapy. Geref International Study Group.J Clin Endocrinol Metab | No random groups | 1996 |
| Plasma GH responses to human GHRH-antagonist in normal subjects.Eur J Endocrinol | No random groups | 1996 |
| Acipimox potentiates growth hormone response to growth hormone-releasing hormone by decreasing serum free fatty acid levels in hyperthyroidism.Metabolism | No random groups | 1995 |
| The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency.J Clin Endocrinol Metab | No random groups | 1995 |
| The effect of a continuous infusion of a somatostatin analogue (octreotide) for two years on growth hormone secretion and height prediction in tall children.Clin Endocrinol (Oxf) | No random groups | 1995 |
| Reciprocal relationship between the level of circulating cortisol and growth hormone secretion in response to growth hormone-releasing hormone in man: studies in patients with adrenal insufficiency.J Clin Endocrinol Metab | No random groups | 1994 |
| Priming with GHRH (1-29) NH2: an aid in differential diagnosis between hypothalamic and pituitary deficiencies.J Pediatr Endocrinol | No random groups | 1994 |
| Long-term therapy with a single daily subcutaneous dose of growth hormone releasing hormone (1-29) in prepubertal growth hormone deficient children. Venezuelan Collaborative Study Group.J Pediatr Endocrinol | No random groups | 1994 |
| Study on growth hormone and insulin secretion in myotonic dystrophy.Clin Investig | No random groups | 1994 |
| Variability in the growth hormone response to growth hormone-releasing hormone alone or combined with pyridostigmine in type 1 diabetic patients.J Endocrinol Invest | No random groups | 1993 |
| Growth hormone (GH) profiles in response to continuous subcutaneous infusion of GH-releasing hormone(1-29)-NH2 in children with GH deficiency.Acta Paediatr Suppl | No random groups | 1993 |
| Intranasal administration of growth hormone-releasing hormone(1-29)-NH2 in children with growth hormone deficiency: effects on growth hormone secretion and growth.Acta Paediatr Suppl | No random groups | 1993 |
| Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons.J Clin Endocrinol Metab | No random groups | 1993 |
| The interaction of GHRH with TRH in acromegaly: a controlled study.Acta Endocrinol (Copenh) | No random groups | 1991 |
| Clonidine pretreatment modifies the growth hormone secretory pattern induced by short-term continuous GRF infusion in normal man.Clin Endocrinol (Oxf) | No random groups | 1991 |
| Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men.J Clin Endocrinol Metab | No random groups | 1991 |
| The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man.Metabolism | No random groups | 1991 |
| The growth hormone response to pyridostigmine plus growth hormone releasing hormone is not influenced by pubertal maturation.J Endocrinol Invest | No random groups | 1991 |
| Inhibitory effect of calcitonin on growth hormone response to growth hormone releasing hormone in acromegaly.Braz J Med Biol Res | No random groups | 1991 |
| Alpha 2-adrenergic agonism enhances the growth hormone (GH) response to GH-releasing hormone through an inhibition of hypothalamic somatostatin release in normal men.J Clin Endocrinol Metab | No random groups | 1990 |
| Effects of GRF (1-29) NH2 on short-term memory: neuroendocrine and neuropsychological assessment in healthy young subjects.Methods Find Exp Clin Pharmacol | No random groups | 1990 |
| Growth hormone response to overnight growth hormone-releasing hormone infusion and oral pyridostigmine in children with short stature.Acta Paediatr Scand Suppl | No random groups | 1989 |
| GH feedback occurs through modulation of hypothalamic somatostatin under cholinergic control: studies with pyridostigmine and GHRH.Clin Endocrinol (Oxf) | No random groups | 1987 |
| Anterior cervical osteophyte-related dysphagia in a long-term growth hormone user: a case report.Front Surg | Case reports | 2026 |
| GHRH excess and blockade in X-LAG syndrome.Endocr Relat Cancer | Case reports | 2016 |
| Suppression of growth hormone (GH) hypersecretion due to ectopic GH-releasing hormone (GHRH) by a selective GHRH antagonist.J Clin Endocrinol Metab | Case reports | 1997 |
| Coexistence of growth hormone-secreting pituitary adenoma and intracranial meningioma: a case report and review of the literature.J Endocrinol Invest | Case reports | 1993 |
| Discordance between growth hormone responses after growth hormone-releasing hormone (GHRH) and insulin hypoglycemia in ectopic GHRH syndrome.Endocrinol Exp | Case reports | 1990 |
| Peptides in urology and sexual medicine: clinical effectiveness, dosing, indications, and safety: a narrative review.Sex Med Rev | Review of studies | 2026 |
| The emerging landscape of performance-enhancing peptides modulating GH-IGF1 axis: bridging the gap between clinical evidence and patient self-administration.Front Endocrinol (Lausanne) | Review of studies | 2026 |
| Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.J Am Acad Orthop Surg Glob Res Rev | Review of studies | 2026 |
| Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males.Transl Androl Urol | Review of studies | 2020 |
| PEGylation of growth hormone-releasing hormone (GRF) analogues.Adv Drug Deliv Rev | Review of studies | 2003 |
| Growth hormone-releasing peptides: clinical and basic aspects.Horm Res | Review of studies | 1996 |
| Growth hormone releasing hormone in the assessment and long-term treatment of growth hormone deficiency.Acta Paediatr Scand Suppl | Review of studies | 1987 |
| An immuno polymerase chain reaction screen for the detection of CJC-1295 and other growth-hormone-releasing hormone analogs in equine plasma.Drug Test Anal | In animals | 2019 |
| Endogenous inhibition of hippocampal LTD and depotentiation by vasoactive intestinal peptide VPAC1 receptors.Hippocampus | In animals | 2014 |
| Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.Peptides | In animals | 2014 |
| Vasoactive intestinal peptide acts via multiple signal pathways to regulate hippocampal NMDA receptors and synaptic transmission.Hippocampus | In animals | 2009 |
| Site-specific PEGylation for high-yield preparation of Lys(21)-amine PEGylated growth hormone-releasing factor (GRF) (1-29) using a GRF(1-29) derivative FMOC-protected at Tyr(1) and Lys(12).Bioconjug Chem | In animals | 2007 |
| Endocrine and orexigenic actions of growth hormone secretagogues in rainbow trout (Oncorhynchus mykiss).Comp Biochem Physiol A Mol Integr Physiol | In animals | 2007 |
| Interactions of GRF(1-29)NH2 with plasma proteins and their effects on the release of the peptide from a PLAGA matrix.J Control Release | In animals | 2005 |
| Regulation of renal NaPi-2 expression and tubular phosphate reabsorption by growth hormone in the juvenile rat.Am J Physiol Renal Physiol | In animals | 2004 |
| Development of an enzyme-linked immunosorbent assay for the measurement of plasma growth hormone (GH) levels in channel catfish (Ictalurus punctatus): assessment of environmental salinity and GH secretogogues on plasma GH levels.Gen Comp Endocrinol | In animals | 2003 |
| Localization and regulation of a functional GHRH receptor in the rat renal medulla.Endocrinology | In animals | 2002 |
| Transcriptional and post-transcriptional regulation of tyrosine hydroxylase messenger RNA in PC12 cells during persistent stimulation by VIP and PACAP38: differential regulation by protein kinase A and protein kinase C-dependent pathways.Neuropeptides | In animals | 2002 |
| Expression of a splice variant of the receptor for GHRH in 3T3 fibroblasts activates cell proliferation responses to GHRH analogs.Proc Natl Acad Sci U S A | In animals | 2002 |
| GH gene expression in the submaxillary gland in normal and Ames dwarf mice.J Endocrinol | In animals | 2001 |
| The hexapeptide KP-102 (D-ala-D-beta-Nal-ala-trp-D-phe-lys-NH(2)) stimulates growth hormone release in a cichlid fish (Ooreochromis mossambicus).J Endocrinol | In animals | 2000 |
| VIP and PACAP potentiation of nicotinic ACh-evoked currents in rat parasympathetic neurons is mediated by G-protein activation.Eur J Neurosci | In animals | 2000 |
| Effect of long-term GHRH and somatostatin administration on GH release and body weight in prepubertal female rats.J Physiol Biochem | In animals | 1999 |
| Differential in vivo regulation of the pituitary growth hormone-releasing hormone (GHRH) receptor by GHRH in young and aged rats.Endocrinology | In animals | 1999 |
| Feeding colostrum increases circulating insulin-like growth factor I in newborn pigs independent of endogenous growth hormone secretion.J Anim Sci | In animals | 1998 |
| Effect of growth hormone-releasing peptide 1-6 on GH secretion-stimulated by GHRH and pyridostigmine in lambs.J Physiol Biochem | In animals | 1998 |
| VIP induces the translocation and degradation of the alpha subunit of Gs protein in rat pituitary GH4C1 cells.J Biochem | In animals | 1998 |
| In vivo effects of the GH-releasing heptapeptide GHRP-1 in lambs.Reprod Nutr Dev | In animals | 1998 |
| The somatotropic axis in neonatal calves can be modulated by nutrition, growth hormone, and Long-R3-IGF-I.Am J Physiol | In animals | 1997 |
| Effects of pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) on hormone secretion from sheep pituitary cells in vitro.J Neuroendocrinol | In animals | 1997 |
| Characterization of VIP receptor-effector system antagonists in rat and mouse peritoneal macrophages.Eur J Pharmacol | In animals | 1997 |
| Expression of vasoactive intestinal polypeptide receptor mRNA and secretory regulation by vasoactive intestinal polypeptide in rat submandibular and sublingual salivary glands.Arch Oral Biol | In animals | 1997 |
| Pituitary adenylate cyclase-activating peptide stimulates amylase release and cyclic adenosine monophosphate production in pancreatic acinar cells.Surgery | In animals | 1996 |
| Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptides (PACAP27) and PACAP38) protect CD4+CD8+ thymocytes from glucocorticoid-induced apoptosis.Blood | In animals | 1996 |
| The effects of GH-releasing peptide-6 (GHRP-6) and GHRP-2 on intracellular adenosine 3',5'-monophosphate (cAMP) levels and GH secretion in ovine and rat somatotrophs.J Endocrinol | In animals | 1996 |
| Somatostatin increases growth hormone (GH) secretion in a subpopulation of porcine somatotropes: evidence for functional and morphological heterogeneity among porcine GH-producing cells.Endocrinology | In animals | 1996 |
| Long-term alterations in growth hormone and insulin secretion after temporary dietary protein restriction in early life in the rat.Pediatr Res | In animals | 1995 |
| Pituitary adenylate cyclase-activating polypeptides (PACAP27 and PACAP38) inhibit the mobility of murine thymocytes and splenic lymphocytes: comparison with VIP and implication of cAMP.J Neuroimmunol | In animals | 1995 |
| Effect of long-acting antagonists of growth hormone (GH)-releasing hormone on GH and cyclic adenosine 3',5'-monophosphate release in superfused rat pituitary cells.Endocrinology | In animals | 1995 |
| The involvement of dipeptidyl peptidase IV in brush-border degradation of GRF(1-29)NH2 by intestinal mucosal cells.J Pharm Pharmacol | In animals | 1995 |
| Effects of acute administration of growth hormone-releasing hormone (GHRH) and oxytocin on somatotroph cells in sheep: morphometric study and growth hormone (GH) secretion.J Endocrinol Invest | In animals | 1995 |
| Interaction between adrenergic and peptide stimulation in the rat pineal: pituitary adenylate cyclase-activating peptide.J Neurochem | In animals | 1995 |
| The effect of GHRH on TSH release in rats in vivo and in vitro.J Endocrinol Invest | In animals | 1995 |
| Inhibitory effect of vasoactive intestinal peptide (VIP) on phagocytosis in mouse peritoneal macrophages.Regul Pept | In animals | 1994 |
| Evidence that endogenous vasoactive intestinal peptide (VIP) is involved in the regulation of rat pituitary-adrenocortical function: in vivo studies with a VIP antagonist.Neuropeptides | In animals | 1994 |
| Subcellular distribution of proteolytic activities degrading bioactive peptides and analogues in the rat small intestinal and colonic enterocytes.J Pharm Pharmacol | In animals | 1994 |
| Early increase in pulsatile growth hormone release after unilateral nephrectomy in adult rats.Am J Physiol | In animals | 1994 |
| Effects in vitro of new growth hormone releasing peptide (GHRP-1) on growth hormone secretion from ovine pituitary cells in primary culture.J Neuroendocrinol | In animals | 1994 |
| The effect of GH-releasing peptide-2 (GHRP-2 or KP 102) on GH secretion from primary cultured ovine pituitary cells can be abolished by a specific GH-releasing factor (GRF) receptor antagonist.J Endocrinol | In animals | 1994 |
| Effect of somatotropin and/or equine chorionic gonadotropin on serum and follicular insulin-like growth factor I and insulin-like growth factor binding proteins in cattle.Biol Reprod | In animals | 1994 |
| Lack of evidence for acute effects of growth hormone-releasing hormone on serum insulin and glucose levels in normal and hypophysectomized rats.Horm Res | In animals | 1994 |
| Feedlot performance, carcass characteristics, hormones, and metabolites in steers actively immunized against growth hormone-releasing factor.J Anim Sci | In animals | 1993 |
| Effects of growth hormone-releasing factor and(or) thyrotropin-releasing hormone on growth, feed efficiency, carcass characteristics, and blood hormones and metabolites in beef heifers.J Anim Sci | In animals | 1993 |
| Commonalities in vasoactive intestinal peptide and peptide N-terminal histidine C-terminal isoleucine stimulation of N-acetyltransferase activity in the rat pineal.J Pineal Res | In animals | 1993 |
| A new target for growth hormone releasing-hormone action in rat: the Sertoli cell.Endocrinology | In animals | 1993 |
| The entire vasoactive intestinal polypeptide molecule is required for the activation of the vasoactive intestinal polypeptide receptor: functional and binding studies on opossum internal anal sphincter smooth muscle.J Pharmacol Exp Ther | In animals | 1993 |
| Interaction of ovine pituitary adenylate cyclase-activating peptide (PACAP-38) with rat lung membranes.Peptides | In animals | 1993 |
| Comparison of the insulinotropic activity of glucagon-superfamily peptides in rat pancreas perfusion.Horm Metab Res | In animals | 1992 |
| Lactation performance of sows injected with growth hormone-releasing factor during gestation and(or) lactation.J Anim Sci | In animals | 1992 |
| Catabolism of rat growth hormone-releasing factor(1-29) amide in rat serum and liver.Peptides | In animals | 1992 |
| Effect of iontophoresis on in vitro skin permeation of an analogue of growth hormone releasing factor in the hairless guinea pig model.J Pharm Sci | In animals | 1992 |
| Evaluation of the biological potency of new agmatine analogs of growth hormone-releasing hormone in the bovine.Proc Soc Exp Biol Med | In animals | 1992 |
| Effect of prepartum administration of growth hormone-releasing factor on somatotropin, insulin-like growth factor I, milk production, and postpartum return to ovarian activity in primiparous beef heifers.J Anim Sci | In animals | 1992 |
| Role of selected endogenous peptides in growth hormone-releasing hexapeptide activity: analysis of growth hormone-releasing hormone, thyroid hormone-releasing hormone, and gonadotropin-releasing hormone.Endocrinology | In animals | 1992 |
| Effect of active immunization against growth hormone releasing factor on concentrations of somatotropin and insulin-like growth factor I in lactating beef cows.Domest Anim Endocrinol | In animals | 1992 |
| Time-dependent reduction and potentiation of growth hormone (GH) responsiveness to GH-releasing factor induced by exogenous GH: role for somatostatin.Endocrinology | In animals | 1992 |
| Advances in the detection of growth hormone releasing hormone synthetic analogs.Drug Test Anal | In a lab dish | 2021 |
| The use of pigs as an animal model to evaluate the efficacy, potency and specificity of two growth hormone releasing factor analogues.Growth Horm IGF Res | In a lab dish | 2001 |
| Antagonistic analogs of growth hormone releasing hormone (GHRH) inhibit cyclic AMP production of human cancer cell lines in vitro.Peptides | In a lab dish | 1999 |
| Effects of peptide T derivatives on the proliferation of cultured human keratinocytes.Arzneimittelforschung | In a lab dish | 1995 |
| Characterization of growth hormone-releasing hormone (GHRH) binding to cloned porcine GHRH receptor.Peptides | In a lab dish | 1995 |
| VIP antagonists enhance excitatory cholinergic neurotransmission in the human airway.Lung | In a lab dish | 1994 |
| Effects of vasoactive intestinal polypeptide antagonists on cholinergic neurotransmission in dog and cat trachea.Br J Pharmacol | In a lab dish | 1991 |
| VIP-ergic and cholinergic innervations in internal carotid arteries of the cat and rat.J Cardiovasc Pharmacol | In a lab dish | 1991 |
| A comparison of the biological activities of authentic rat GRF(1-43)OH with the analogue rat GRF(1-29)NH2.Can J Physiol Pharmacol | In a lab dish | 1991 |
| Analogues of growth hormone-releasing factor (1-29) amide containing the reduced peptide bond isostere in the N-terminal region.J Med Chem | In a lab dish | 1990 |
| A glucagon-secretin-like peptide stimulates the intrinsic nervous plexus of guinea pig gallbladder.Experientia | In a lab dish | 1990 |
| Secretory actions of vasoactive intestinal polypeptide, peptide histidine isoleucine and helodermin in rat small intestine: the effects of putative VIP antagonists upon VIP-induced ion secretion.Regul Pept | In a lab dish | 1989 |
| Analogues of vasoactive intestinal peptide (VIP) contract the guinea-pig uterine artery but do not antagonize VIP-induced relaxations.Eur J Pharmacol | In a lab dish | 1989 |
| The effects of vasoactive intestinal peptide (VIP) antagonists, and VIP and peptide histidine isoleucine antisera on non-adrenergic, non-cholinergic relaxations of tracheal smooth muscle.Br J Pharmacol | In a lab dish | 1989 |
| The effects of antagonists of vasoactive intestinal peptide on nonadrenergic noncholinergic inhibitory responses in feline airways.Peptides | In a lab dish | 1988 |
| The synthetic peptide GRF (1-29)-NH2 with growth hormone releasing activity penetrates human epidermis in nitro.Acta Pharm Suec | In a lab dish | 1988 |
| Differential effects of N-terminal modifications on the biological potencies of growth hormone releasing factor analogues with varying chain lengths.J Med Chem | In a lab dish | 1987 |
| Specific labelling of high-affinity vasoactive intestinal peptide receptors in rat liver membranes by a growth hormone-releasing factor analog.Neuroendocrinology | In a lab dish | 1986 |
| Comparative structural requirements of thirty GRF analogs for interaction with GRF- and VIP receptors and coupling to adenylate cyclase in rat adenopituitary, liver and pancreas.Peptides | In a lab dish | 1986 |
| Interaction of growth hormone-releasing factor (GRF) and 14 GRF analogs with vasoactive intestinal peptide (VIP) receptors of rat pancreas. Discovery of (N-Ac-Tyr1,D-Phe2)-GRF(1-29)-NH2 as a VIP antagonist.Endocrinology | In a lab dish | 1985 |
| Analysis of growth hormone releasing hormone and its analogs in urine using nano liquid chromatography coupled with quadrupole/orbitrap mass spectrometry.J Pharm Biomed Anal | Other paper | 2026 |
| Universal peptide synthesis via solid-phase methods fused with chemputation.Nat Commun | Other paper | 2025 |
| Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.J Mass Spectrom | Other paper | 2024 |
| Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samples.Anal Biochem | Other paper | 2023 |
| In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides.Biomed Chromatogr | Other paper | 2023 |
| Online large volume sample staking preconcentration and separation of enantiomeric GHRH analogs by capillary electrophoresis.Electrophoresis | Other paper | 2023 |
| Probing for peptidic drugs (2-10 kDa) in doping control blood samples.Anal Sci Adv | Other paper | 2022 |
| An antibody-free, ultrafiltration-based assay for the detection of growth hormone-releasing hormones in urine at low pg/mL concentrations using nanoLC-HRMS/MS.J Pharm Biomed Anal | Other paper | 2022 |
| A potentially effective drug for patients with recurrent glioma: sermorelin.Ann Transl Med | Other paper | 2021 |
| Comparison of magnetic bead surface functionalities for the immunopurification of growth hormone-releasing hormones prior to liquid chromatography-high resolution mass spectrometry.J Chromatogr A | Other paper | 2020 |
| Exploring the Conformational Space of Growth-Hormone-Releasing Hormone Analogues Using Dopant Assisted Trapped Ion Mobility Spectrometry-Mass Spectrometry.J Phys Chem B | Other paper | 2019 |
| Glycine-modified growth hormone secretagogues identified in seized doping material.Drug Test Anal | Other paper | 2019 |
| Structural Motif Descriptors as a Way To Elucidate the Agonistic or Antagonistic Activity of Growth Hormone-Releasing Hormone Peptide Analogues.ACS Omega | Other paper | 2018 |
| Growth hormone-releasing hormone (GHRH) and its agonists inhibit hepatic and tumoral secretion of IGF-1.Oncotarget | Other paper | 2018 |
| Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels.Am J Mens Health | Other paper | 2017 |
| Synthesis and structure-activity studies on novel analogs of human growth hormone releasing hormone (GHRH) with enhanced inhibitory activities on tumor growth.Peptides | Other paper | 2017 |
| Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS.Anal Bioanal Chem | Other paper | 2016 |
| Operation resistance: A snapshot of falsified antibiotics and biopharmaceutical injectables in Europe.Drug Test Anal | Other paper | 2016 |
| Expanded test method for peptides >2 kDa employing immunoaffinity purification and LC-HRMS/MS.Drug Test Anal | Other paper | 2015 |
| The GHRH + arginine stimulated pituitary GH secretion in children and adults with Prader-Willi syndrome shows age- and BMI-dependent and genotype-related differences.Growth Horm IGF Res | Other paper | 2013 |
| Macimorelin (AEZS-130)-stimulated growth hormone (GH) test: validation of a novel oral stimulation test for the diagnosis of adult GH deficiency.J Clin Endocrinol Metab | Other paper | 2013 |
| Growth hormone-releasing hormone receptor splice variant 1 is frequently expressed in oral squamous cell carcinomas.Horm Cancer | Other paper | 2012 |
| GHRH antagonist MZ-5-156 increases the expression of AMPK in A549 lung cancer cells.Cell Cycle | Other paper | 2011 |
| Activation of mitogen-activated protein kinases by a splice variant of GHRH receptor.J Mol Endocrinol | Other paper | 2010 |
| Repetitive stimulation of the pituitary with growth-hormone-releasing hormone alters the proportion of 22 and 20 kilodalton human-growth hormone released.Int J Pediatr Endocrinol | Other paper | 2010 |
| Stimulatory effect of growth hormone-releasing hormone (GHRH(1-29)NH2) on the proliferation, VEGF and chromogranin A secretion by human neuroendocrine tumor cell line NCI-H727 in vitro.Neuropeptides | Other paper | 2009 |
| Inhibition of estrogen receptor positive and negative breast cancer cell lines with a growth hormone-releasing hormone antagonist.Oncol Rep | Other paper | 2008 |
| Knocking down gene expression for growth hormone-releasing hormone inhibits proliferation of human cancer cell lines.Br J Cancer | Other paper | 2008 |
| Lipopeptide antagonists of growth hormone-releasing hormone with improved antitumor activities.Proc Natl Acad Sci U S A | Other paper | 2006 |
| Antagonist of growth hormone-releasing hormone induces apoptosis in LNCaP human prostate cancer cells through a Ca2+-dependent pathway.Proc Natl Acad Sci U S A | Other paper | 2005 |
| Chromatographic separation and mass spectrometric identification of positional isomers of polyethylene glycol-modified growth hormone-releasing factor (1-29).J Chromatogr A | Other paper | 2004 |
| Pharmacodynamic evaluation of a PEGylated analogue of human growth hormone releasing factor in rats and pigs.Growth Horm IGF Res | Other paper | 2004 |
| Mechanism of action of the growth hormone secretagogue, L-692,585, on isolated porcine somatotropes.J Endocrinol | Other paper | 2002 |
| The expression of growth hormone-releasing hormone (GHRH) and splice variants of its receptor in human gastroenteropancreatic carcinomas.Proc Natl Acad Sci U S A | Other paper | 2002 |
| [Effect of transdermal administration of 17-beta estradiol on the release of growth hormone by growth hormone liberating hormone (GH-RH-1-29) in climacteric women before and after treatment].Ginecol Obstet Mex | Other paper | 2001 |
| Contribution of growth hormone-releasing hormone and somatostatin to decreased growth hormone secretion in elderly men.S Afr Med J | Other paper | 2001 |
| Growth during and after a trial of growth hormone releasing hormone 1-29 in children with idiopathic short stature or growth hormone neurosecretory dysfunction.J Pediatr Endocrinol Metab | Other paper | 2000 |
| Interaction of the novel GH secretagogue hexarelin with GHRH in regulating the secretion of GH by cultured human pituitary somatotrophinomas in vitro.J Tongji Med Univ | Other paper | 2000 |
| Growth hormone-releasing hormone: an autocrine growth factor for small cell lung carcinoma.Proc Natl Acad Sci U S A | Other paper | 1999 |
| In vivo semiquantification of hypothalamic growth hormone-releasing hormone (GHRH) output in humans: evidence for relative GHRH deficiency in aging.J Clin Endocrinol Metab | Other paper | 1999 |
| Predicting bull growth performance and carcass composition from growth hormone response to growth hormone-releasing hormone.J Anim Sci | Other paper | 1999 |
| Effects of active immunization against growth-hormone releasing factor on puberty and reproductive development in gilts.J Anim Sci | Other paper | 1999 |
| Functional characterization of a receptor for vasoactive-intestinal-peptide-related peptides in cultured dermal melanophores from Xenopus laevis.Pigment Cell Res | Other paper | 1999 |
| Expression of growth hormone-releasing hormone (GHRH) messenger ribonucleic acid and the presence of biologically active GHRH in human breast, endometrial, and ovarian cancers.J Clin Endocrinol Metab | Other paper | 1999 |
| The growth hormone response to hexarelin in patients with Prader-Willi syndrome.J Endocrinol Invest | Other paper | 1998 |
| Growth hormone-releasing peptide-2 (GHRP-2) does not act via the human growth hormone-releasing factor receptor in GC cells.Endocrine | Other paper | 1998 |
| Presence of GHRH mRNA in human pituitary somatotrophinomas and its relationship to in vitro effect of a GHRH-antagonist on GH secretion and cAMP production.Pituitary | Other paper | 1998 |
| Human growth hormone-releasing hormone hGHRH(1-29)-NH2: systematic structure-activity relationship studies.J Med Chem | Other paper | 1998 |
| New analogs of human growth hormone-releasing hormone (1-29) with high and prolonged antagonistic activity.J Pept Res | Other paper | 1998 |
| Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.Clin Endocrinol (Oxf) | Other paper | 1997 |
| Inhibitory effects of galanin on growth hormone (GH) release in cultured GH-secreting adenoma cells: comparative study with octreotide, GH-releasing hormone, and thyrotropin-releasing hormone.Metabolism | Other paper | 1997 |
| Glutamate decarboxylase autoimmunity and growth hormone secretion in type I diabetes mellitus.Metabolism | Other paper | 1997 |
| Presence of a bioactive and immunoreactive growth-hormone-releasing-factor-like substance in porcine placenta.Biol Neonate | Other paper | 1997 |
| Nocturnal growth hormone (GH) secretion is eliminated by infusion of GH-releasing hormone antagonist.J Clin Endocrinol Metab | Other paper | 1996 |
| Growth hormone response to growth hormone-releasing hormone varies with the hypothalamic-pituitary abnormalities.Eur J Endocrinol | Other paper | 1996 |
| Evaluation of growth hormone (GH) responses to pulsed GH-releasing hormone administration using the MTT-ESTA bioassay.Eur J Endocrinol | Other paper | 1996 |
| Hypothalamic control of growth hormone (GH) secretion in type I diabetic men: effect of the combined administration of GH-releasing hormone and hexarelin, a novel GHRP-6 analog.Endocr Res | Other paper | 1996 |
| Stable expression of the recombinant human VIP1 receptor in clonal Chinese hamster ovary cells: pharmacological, functional and molecular properties.Eur J Pharmacol | Other paper | 1996 |